Company intelligence / Profile preview
Grand-Sevax Life Sciences
Hyderabad, Telangana, Indiagrandsevax.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Grand-Sevax Life Sciences is an Indian biotechnology company dedicated to the discovery and development of innovative pharmaceutical products and vaccines. Based in the pharmaceutical hub of Hyderabad, the company focuses on high-impact therapeutic areas including oncology and infectious diseases. Since its inception in 2021, Grand-Sevax has worked to build a robust research infrastructure to support its early-stage pipeline. The firm aims to translate complex biological insights into accessible healthcare solutions for both domestic and international markets. Its leadership team brings expertise in drug formulation and clinical research to the emerging enterprise.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Grand-Sevax Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grand-Sevax Life Sciences.